DENVER—An experimental iron-based phosphate binder is effective for treating hyperphosphatemia in hemodialysis (HD) patients, and is well tolerated, new data show. James A. Tumlin, MD, and colleagues ...
In 2 studies, roughly a third of hemodialysis patients achieved within-range serum phosphate levels after converting to sucroferric oxyhydroxide from another phosphate binder. Switching to the ...
Nitrogen-containing heteroaromatic-based inhibitors for cytochrome P450 (CYP) in various species contain a crucial coordination between the nitrogen atom and the heme iron. Previous studies suggested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results